Speech Linguistic and Acoustic Markers in Parkinson's Disease

  • STATUS
    Recruiting
  • participants needed
    150
  • sponsor
    University of Massachusetts, Worcester
Send
Updated on 19 February 2024
See if I qualify
parkinson's disease
cognitive impairment
cognitive decline
mild cognitive impairment
mental deterioration

Summary

We aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. We will administer various speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. We will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

Details
Condition Speech, Parkinson's Disease, Parkinson's Disease, Cognitive Impairment, Mild
Age 18years - 100years
Treatment Cognitive Battery, Voice, Speech and Language Analysis, Questionnaires and Clinical Assessments, DNA Analysis
Clinical Study IdentifierNCT04273672
SponsorUniversity of Massachusetts, Worcester
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Parkinson's Disease (or healthy control)
Disease duration 2 years
Mild cognitive impairment or normal cognition

Exclusion Criteria

Diagnosis of dementia (MoCA <21)
Adults unable to consent
Age < 18
Pregnant women
Prisoners
Non-English speakers
Any neurological disorder other than PD
Deep brain stimulator placement
Severe, unstable psychiatric disorder
Unintelligible speech due to effects of PD
Visual acuity or color vision impairment that would interfere with cognitive testing
Other voice, speech or swallowing disorders or history of surgery involving palate/nasopharynx/larynx/vocal cords
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

parkinson's disease
cognitive impairment
cognitive decline
mild cognitive impairment
mental deterioration

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.